vs
富兰克林邓普顿（BEN）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
富兰克林邓普顿的季度营收约是瑞思迈的1.6倍（$2.3B vs $1.4B），瑞思迈净利率更高（27.6% vs 11.0%，领先16.6%），瑞思迈同比增速更快（11.0% vs 3.4%），过去两年瑞思迈的营收复合增速更高（9.0% vs 4.0%）
富兰克林资源（运营品牌为富兰克林邓普顿）是美国跨国投资管理控股集团，1947年创立于纽约，纽交所上市代码为BEN，命名源自创始人敬仰的本杰明·富兰克林，是全球知名的综合投资服务机构。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
BEN vs RMD — 直观对比
营收规模更大
BEN
是对方的1.6倍
$1.4B
营收增速更快
RMD
高出7.6%
3.4%
净利率更高
RMD
高出16.6%
11.0%
两年增速更快
RMD
近两年复合增速
4.0%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.3B | $1.4B |
| 净利润 | $255.5M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 12.1% | 34.6% |
| 净利率 | 11.0% | 27.6% |
| 营收同比 | 3.4% | 11.0% |
| 净利润同比 | 56.2% | 13.9% |
| 每股收益（稀释后） | $0.46 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BENRMD
| Q4 25 | $2.3B | $1.4B | ||
| Q3 25 | $2.3B | $1.3B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.1B | $1.3B | ||
| Q4 24 | $2.3B | $1.3B | ||
| Q3 24 | $2.2B | $1.2B | ||
| Q2 24 | $2.1B | $1.2B | ||
| Q1 24 | $2.2B | $1.2B |
净利润BENRMD
| Q4 25 | $255.5M | $392.6M | ||
| Q3 25 | $117.6M | $348.5M | ||
| Q2 25 | $92.3M | $379.7M | ||
| Q1 25 | $151.4M | $365.0M | ||
| Q4 24 | $163.6M | $344.6M | ||
| Q3 24 | $-84.7M | $311.4M | ||
| Q2 24 | $174.0M | $292.2M | ||
| Q1 24 | $124.2M | $300.5M |
毛利率BENRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率BENRMD
| Q4 25 | 12.1% | 34.6% | ||
| Q3 25 | 3.6% | 33.4% | ||
| Q2 25 | 7.5% | 33.7% | ||
| Q1 25 | 6.9% | 33.0% | ||
| Q4 24 | 9.7% | 32.5% | ||
| Q3 24 | -6.8% | 31.6% | ||
| Q2 24 | 10.5% | 31.2% | ||
| Q1 24 | 6.0% | 31.3% |
净利率BENRMD
| Q4 25 | 11.0% | 27.6% | ||
| Q3 25 | 5.0% | 26.1% | ||
| Q2 25 | 4.5% | 28.2% | ||
| Q1 25 | 7.2% | 28.3% | ||
| Q4 24 | 7.3% | 26.9% | ||
| Q3 24 | -3.8% | 25.4% | ||
| Q2 24 | 8.2% | 23.9% | ||
| Q1 24 | 5.8% | 25.1% |
每股收益（稀释后）BENRMD
| Q4 25 | $0.46 | $2.68 | ||
| Q3 25 | $0.21 | $2.37 | ||
| Q2 25 | $0.15 | $2.58 | ||
| Q1 25 | $0.26 | $2.48 | ||
| Q4 24 | $0.29 | $2.34 | ||
| Q3 24 | $-0.20 | $2.11 | ||
| Q2 24 | $0.32 | $1.97 | ||
| Q1 24 | $0.23 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $2.4B | $403.9M |
| 股东权益账面价值 | $12.1B | $6.3B |
| 总资产 | $32.5B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资BENRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务BENRMD
| Q4 25 | $2.4B | $403.9M | ||
| Q3 25 | $2.4B | $408.7M | ||
| Q2 25 | $2.7B | $658.4M | ||
| Q1 25 | $2.7B | $663.1M | ||
| Q4 24 | $2.8B | $662.9M | ||
| Q3 24 | $2.8B | $667.6M | ||
| Q2 24 | $3.0B | $697.3M | ||
| Q1 24 | $3.0B | $997.0M |
股东权益BENRMD
| Q4 25 | $12.1B | $6.3B | ||
| Q3 25 | $12.1B | $6.1B | ||
| Q2 25 | $12.2B | $6.0B | ||
| Q1 25 | $12.3B | $5.5B | ||
| Q4 24 | $12.5B | $5.3B | ||
| Q3 24 | $12.5B | $5.2B | ||
| Q2 24 | $12.9B | $4.9B | ||
| Q1 24 | $12.9B | $4.6B |
总资产BENRMD
| Q4 25 | $32.5B | $8.5B | ||
| Q3 25 | $32.4B | $8.3B | ||
| Q2 25 | $32.6B | $8.2B | ||
| Q1 25 | $32.0B | $7.6B | ||
| Q4 24 | $32.4B | $7.1B | ||
| Q3 24 | $32.5B | $7.2B | ||
| Q2 24 | $33.3B | $6.9B | ||
| Q1 24 | $32.9B | $6.8B |
负债/权益比BENRMD
| Q4 25 | 0.19× | 0.06× | ||
| Q3 25 | 0.20× | 0.07× | ||
| Q2 25 | 0.22× | 0.11× | ||
| Q1 25 | 0.22× | 0.12× | ||
| Q4 24 | 0.22× | 0.13× | ||
| Q3 24 | 0.22× | 0.13× | ||
| Q2 24 | 0.24× | 0.14× | ||
| Q1 24 | 0.24× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-255.1M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | — | $311.2M |
| 自由现金流率自由现金流/营收 | — | 21.9% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | -1.00× | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流BENRMD
| Q4 25 | $-255.1M | $339.7M | ||
| Q3 25 | $-20.7M | $457.3M | ||
| Q2 25 | $1.3B | $538.8M | ||
| Q1 25 | $-50.1M | $578.7M | ||
| Q4 24 | $-145.2M | $308.6M | ||
| Q3 24 | $558.2M | $325.5M | ||
| Q2 24 | $528.4M | $440.1M | ||
| Q1 24 | $136.6M | $402.0M |
自由现金流BENRMD
| Q4 25 | — | $311.2M | ||
| Q3 25 | $-51.9M | $414.4M | ||
| Q2 25 | $1.3B | $508.2M | ||
| Q1 25 | $-87.6M | $557.9M | ||
| Q4 24 | $-217.0M | $288.0M | ||
| Q3 24 | $488.4M | $307.7M | ||
| Q2 24 | $482.3M | $415.2M | ||
| Q1 24 | $94.9M | $380.8M |
自由现金流率BENRMD
| Q4 25 | — | 21.9% | ||
| Q3 25 | -2.2% | 31.0% | ||
| Q2 25 | 61.4% | 37.7% | ||
| Q1 25 | -4.1% | 43.2% | ||
| Q4 24 | -9.6% | 22.5% | ||
| Q3 24 | 22.1% | 25.1% | ||
| Q2 24 | 22.7% | 33.9% | ||
| Q1 24 | 4.4% | 31.8% |
资本支出强度BENRMD
| Q4 25 | — | 2.0% | ||
| Q3 25 | 1.3% | 3.2% | ||
| Q2 25 | 0.7% | 2.3% | ||
| Q1 25 | 1.8% | 1.6% | ||
| Q4 24 | 3.2% | 1.6% | ||
| Q3 24 | 3.2% | 1.5% | ||
| Q2 24 | 2.2% | 2.0% | ||
| Q1 24 | 1.9% | 1.8% |
现金转化率BENRMD
| Q4 25 | -1.00× | 0.87× | ||
| Q3 25 | -0.18× | 1.31× | ||
| Q2 25 | 13.89× | 1.42× | ||
| Q1 25 | -0.33× | 1.59× | ||
| Q4 24 | -0.89× | 0.90× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | 3.04× | 1.51× | ||
| Q1 24 | 1.10× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BEN
| Investment Advisory Management And Administrative Service | $1.8B | 79% |
| Sales And Distribution Fees | $388.7M | 17% |
| Shareholder Service | $70.9M | 3% |
| Service Other | $19.6M | 1% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
